Lantern Pharma: Redefining Oncology Drug Development with A.I. and Machine Learning
Lantern Pharma (NASDAQ: LTRN) is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, our newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program. Visit LTRNinfo.com to learn more.
-
0:17
RedChip
1 year agoLantern Pharma: Redefining Oncology Drug Development with A.I. and Machine Learning
11 -
1:54
RedChip
10 months agoLantern Pharma: Using AI to Transform Drug Development
15 -
21:30
jess93
1 month agoBig Pharma CEO PFIZER New Blockbuster Drugs Saving The World and His Prediction About Cancer Drug
611 -
1:39
thestonebuildersrejected
11 months agoAI Applications In Drug Development And Discovery
4 -
4:13
The Igonrant Entrepreneur
11 months agoThe First AI-Generated Drug Enters Human Trials, Pioneering a New Era in Medicine!
22 -
27:24
TheRealTruthAboutHealth
6 months agoPioneering Personalized Treatments for Advanced Cancers: A Conversation with Dr. Dawn Lemanne
215 -
27:24
TheRealTruthAboutHealth
6 months agoPioneering Personalized Treatments for Advanced Cancers: A Conversation with Dr. Dawn Lemanne
76 -
2:53
AMERICAXPOSED
1 year agoPfizer CEO Albert Bourla Announces Acquisition of Cancer Treatment Biotech Seagen For $43 Billion
208 -
1:54
Healthprep
4 years agoMajor Breakthrough Cancer Cures
7.69K -
7:34
The Furrowed Brow with Jeffrey Kibler
1 year agoPrediction Markets for Drug Discovery